These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11899231)

  • 21. Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.
    Herbert A
    Thorax; 1986 Mar; 41(3):176-89. PubMed ID: 3520935
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
    Byrne AJ; Maher TM; Lloyd CM
    Trends Mol Med; 2016 Apr; 22(4):303-316. PubMed ID: 26979628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of eosinophils in pulmonary fibrosis (Review).
    Gharaee-Kermani M; Phan SH
    Int J Mol Med; 1998 Jan; 1(1):43-53. PubMed ID: 9852197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?
    Marshall RP; McAnulty RJ; Laurent GJ
    Int J Biochem Cell Biol; 1997 Jan; 29(1):107-20. PubMed ID: 9076945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of epithelial cell apoptosis in interstitial lung diseases.
    Kuwano K
    Intern Med; 2008; 47(5):345-53. PubMed ID: 18310962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TGF-beta in pulmonary fibrosis.
    Khalil N; Greenberg AH
    Ciba Found Symp; 1991; 157():194-207; discussion 207-11. PubMed ID: 1712697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunology of idiopathic pulmonary fibrosis.
    Agostini C; Semenzato G
    Curr Opin Pulm Med; 1996 Sep; 2(5):364-9. PubMed ID: 9363169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic pulmonary fibrosis: from biopathology to treatment].
    Wallaert B; Lamblin C
    Rev Prat; 2000 Nov; 50(17):1906-10. PubMed ID: 11151332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression?
    Knight DA; Ernst M; Anderson GP; Moodley YP; Mutsaers SE
    Pharmacol Ther; 2003 Sep; 99(3):327-38. PubMed ID: 12951164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.
    White ES; Lazar MH; Thannickal VJ
    J Pathol; 2003 Nov; 201(3):343-54. PubMed ID: 14595745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Effects of Functional Amino Acids on Apoptosis, Inflammatory Response, and Pulmonary Fibrosis in Lipopolysaccharide-Challenged Mice.
    Ma X; Zhang Y; Jiang D; Yang Y; Wu G; Wu Z
    J Agric Food Chem; 2019 May; 67(17):4915-4922. PubMed ID: 31001980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathobiology of pulmonary fibrosis.
    Crouch E
    Am J Physiol; 1990 Oct; 259(4 Pt 1):L159-84. PubMed ID: 2221080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis.
    Adamson IY; Young L; Bowden DH
    Am J Pathol; 1988 Feb; 130(2):377-83. PubMed ID: 3341452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis.
    Weissler JC
    Am J Med Sci; 1989 Feb; 297(2):91-104. PubMed ID: 2919636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis].
    Brunetti G; Pignatti P
    Recenti Prog Med; 2007 Feb; 98(2):90-6. PubMed ID: 17439069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.
    Nagao S; Taguchi K; Sakai H; Tanaka R; Horinouchi H; Watanabe H; Kobayashi K; Otagiri M; Maruyama T
    Biomaterials; 2014 Aug; 35(24):6553-62. PubMed ID: 24811261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of pulmonary fibrosis.
    Thannickal VJ; Toews GB; White ES; Lynch JP; Martinez FJ
    Annu Rev Med; 2004; 55():395-417. PubMed ID: 14746528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity.
    Königshoff M
    Respiration; 2011; 81(5):353-8. PubMed ID: 21502777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.